Italia markets open in 4 hours 19 minutes

Dow Jones
39.908,00
+349,89(+0,88%)
Nasdaq
16.742,39
+231,21(+1,40%)
Nikkei 225
38.626,98
+241,25(+0,63%)
EUR/USD
1,0891
+0,0004(+0,03%)
Bitcoin EUR
60.605,36
+3.882,20(+6,84%)
CMC Crypto 200
1.391,79
+123,84(+9,77%)

NVCR Dec 2025 20.000 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

7,70

+4,40

(+133,33%)

In data: 03:26PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in